← Leaderboards
Jordan Fong
Gradient Medical, Inc.
$1,086,463
Attributed
$1,661,463
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,661,463 · 3
By mechanism
R42$1,150,000 · 1
R41$259,549 · 1
R43$251,914 · 1
Top collaborators
- Michael Benjamin Sano1 shared
Most similar at Gradient Medical, Inc.
Same institution · by research overlap
- Matthew R Dewitt$255,930
Others in their field
Other Emerging Leaders on “Safety”
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
- Kimberly Smith · Ppd Development Lp$122,008,792
- Klaus Romero · Critical Path Institute$90,404,592
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$75,904,237
- Yunda Huang · Fred Hutchinson Cancer Center$70,809,823
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
Research focus
SafetyElectroporationPhysiologic PulseTechnologyCell MembraneElectric FieldGenerationsMinimally InvasiveTissuesAnimalsDesignMalignant NeoplasmsBile DuctAblationDiagnosisBaseCustomDoseCancer TherapyChemotherapyCancer EtiologyChargeAnimal ModelCells
Grant awards (3)
Commercialization of Algorithmic Non-thermal Ablation Technology for the Treatment of Inoperable Tumors$1,150,000
R42 · FY2025 · CA · contact PI
Feasibility of a Multi-Phase Algorithmic Non-Thermal Ablation Technology for the Treatment of Inoperable Tumors$259,549
R41 · FY2022 · CA · contact PI
Feasibility of INSPIRE Technology to Enhance CRISPR Mediated Genome Editors In Vivo$251,914
R43 · FY2021 · GM · contact PI